Quick Search

Products

ERGIC2 (ERGIC and golgi 2) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated

0 reviews | Write a Review Pencil

Description
Additional Information

This is a synthetic peptide designed for use in combination with anti-ERGIon Channel2 antibody (Catalogue #: ARP39265_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

See Full Product Listings >

Antibodies

ELISA / Assay / CLIA Kits

Proteins & Peptides

Reagents

RNAi / Lysates / Slides & more...

About Absave

Absave is the leading savings website for Antibodies and Immunological Products. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else!

Get the Best Promotions

Privacy Policy | Terms & Conditions | About Us | Contact Us

Presku:	AAP39265
Size:	100 ug
Weight:	43kDa
Gene:	51290
Format:	Lyophilized powder
Target:	ERGIon Channel2 possibly play role in transport between endoplasmic reticulum and Golgi. ERGIon Channel2 is downregulated in prostate cancer. ERGIon Channel2 may play an important role in the growth and tumorigenicity of PC-3 prostate tumor cells. Ectopic expression of a partial sequence of ERGIon Channel2 as a VP22-fusion protein in prostate cancer cell line, PC-3, induced cellular senescence. Interferon-beta (IFN-beta) and a number of IFN-inducible genes were upregulated by the ERGIon Channel2-VP22 fusion protein.

ERGIC2 (ERGIC and golgi 2) Blocking Peptide (100ug)

About Absave

Product Categories

Information